AMICUS THERAPEUTICS, INC.
|
25,182,364
|
$379,750,000
|
6.15%
|
No Change
|
+$147,065,000
|
Global Blood Therapeutics, Inc.
|
5,842,100
|
$368,811,000
|
5.98%
|
-223,626
|
+$58,914,000
|
Retrophin, Inc.
NOTE 2.500% 9/1
|
45,000,000
|
$349,979,000
|
5.67%
|
New
|
+$349,979,000
|
IOVANCE BIOTHERAPEUTICS, INC.
|
11,809,494
|
$324,170,000
|
5.25%
|
+139,437
|
-$25,173,000
|
Mirati Therapeutics, Inc.
|
2,771,050
|
$316,371,000
|
5.13%
|
-548,400
|
+$61,204,000
|
NEUROCRINE BIOSCIENCES INC
|
2,141,410
|
$261,252,000
|
4.23%
|
-921,853
|
-$3,874,000
|
CYTOKINETICS INC
NOTE 4.000%11/1
|
10,000,000
|
$238,260,000
|
3.86%
|
New
|
+$238,260,000
|
BridgeBio Pharma, Inc.
|
6,706,268
|
$218,691,000
|
3.54%
|
No Change
|
+$24,210,000
|
Kodiak Sciences Inc.
|
3,513,572
|
$190,154,000
|
3.08%
|
-149,985
|
+$15,402,000
|
VBI Vaccines Inc/BC
|
55,042,465
|
$170,631,000
|
2.76%
|
New
|
+$170,631,000
|
COLLEGIUM PHARMACEUTICAL, INC
NOTE 2.625% 2/1
|
17,500,000
|
$157,227,000
|
2.55%
|
New
|
+$157,227,000
|
Athenex, Inc.
|
11,532,467
|
$155,935,000
|
2.53%
|
No Change
|
+$66,674,000
|
SpringWorks Therapeutics, Inc.
|
3,514,358
|
$147,603,000
|
2.39%
|
+30,000
|
+$53,525,000
|
MyoKardia, Inc.
|
1,395,017
|
$134,787,000
|
2.18%
|
+80,808
|
+$73,176,000
|
ZOGENIX, INC.
|
4,907,139
|
$132,542,000
|
2.15%
|
New
|
+$132,542,000
|
Zymeworks Inc.
|
3,580,999
|
$129,166,000
|
2.09%
|
+20,000
|
+$3,074,000
|
NEVRO CORP
NOTE 2.750% 4/0
|
9,000,000
|
$121,500,000
|
1.97%
|
New
|
+$121,500,000
|
NEVRO CORP
|
899,972
|
$107,520,000
|
1.74%
|
-192,096
|
+$71,000
|
Quotient Ltd
|
13,289,054
|
$98,338,000
|
1.59%
|
No Change
|
+$45,847,000
|
MeiraGTx Holdings plc
|
6,433,277
|
$80,544,000
|
1.31%
|
No Change
|
-$5,919,000
|
Kadmon Holdings, Inc.
|
15,711,334
|
$80,442,000
|
1.30%
|
No Change
|
+$14,612,000
|
Frequency Therapeutics, Inc.
|
3,034,296
|
$70,547,000
|
1.14%
|
No Change
|
+$16,507,000
|
ARENA PHARMACEUTICALS INC
|
1,095,129
|
$68,938,000
|
1.12%
|
New
|
+$68,938,000
|
Allogene Therapeutics, Inc.
|
1,543,790
|
$66,105,000
|
1.07%
|
No Change
|
+$36,094,000
|
Provention Bio, Inc.
|
4,525,711
|
$63,858,000
|
1.03%
|
+1,514,137
|
+$36,151,000
|